T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
about
T lymphocyte SHP2-deficiency triggers anti-tumor immunity to inhibit colitis-associated cancer in mice.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@en
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@nl
type
label
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@en
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@nl
prefLabel
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@en
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@nl
P2093
P2860
P356
P1433
P1476
T lymphocyte SHP2-deficiency t ...... tis-associated cancer in mice.
@en
P2093
GenSheng Feng
Lihong Shen
Wenjie Guo
Xiaolin Luo
Yanhong Gu
Yongqian Shu
P2860
P304
P356
10.18632/ONCOTARGET.13812
P407
P577
2016-12-07T00:00:00Z